Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites

World Journal of Gastroenterology

Volumn 19, Issue 25, 2013, Pages 4053-4059

  Gao, Qiao Ying ^a   Liu, Hong Bin ^a   Li, Dong Hua ^a   Wu, Shang Wei ^a  

^a TIANJIN NANKAI HOSPITAL   (China)

Author keywords

Escherichia coli; Pathogens; Probiotics; Sepsis; Staphylococcus aureus

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCITES; BACTERIAL COUNT; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; ESCHERICHIA COLI; HISTOLOGY; LACTOBACILLUS BULGARICUS; MALE; MICROBIAL SENSITIVITY TEST; MUCOSAL DISEASE; MUCOSAL INFLAMMATION; NONHUMAN; PARASITE CULTIVATION; PATHOGENESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS THERMOPHILUS; SURVIVAL RATE;

EID: 84880149644     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i25.4053     Document Type: Article

References (30)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150 [PMID: 12519925 DOI: 10.1056/NEJMra021333]
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554 [PMID: 12700374 DOI: 10.1056/NEJMoa022139]
3. Russell JA. Management of sepsis. N Engl J Med 2006; 355: 1699-1713 [PMID: 17050894 DOI: 10.1056/NEJMra043632]
4. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125-1128 [PMID: 8674323 DOI: 10.1097/0 0003246-199607000-00010]
5. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the motor of critical illness. Shock 2007; 28: 384-393 [PMID: 17577136 DOI: 10.1097/ shk.0b013e31805569df]
6. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920 [PMID: 15790844 DOI: 10.1126/sci- ence.1104816]
7. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock 2005; 24 Suppl 1: 52-57 [PMID: 16374373 DOI: 10.1097/01.shk.0000191414.94461.7e]
8. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005; 4: 854-865 [PMID: 16224456 DOI: 10.1038/nrd1854]
9. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221 [PMID: 15502843 DOI: 10.1038/nm1124]
10. Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 2006; 177: 7943-7949 [PMID: 17114466]
11. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immuno-design of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31-36 [PMID: 19131954 DOI: 10.1038/ 22 nprot.2008.214]
12. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics--approaching a definition. Am J Clin Nutr 2001; 73: 23 361S-364S [PMID: 11157342]
13. O'Keefe SJ. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 2008; 24: 51-58 [PMID: 24 18043233]
14. O'Keefe SJ, Ou J, Aufreiter S, O'Connor D, Sharma S, Sepulveda J, Fukuwatari T, Shibata K, Mawhinney T. Products of the colonic microbiota mediate the effects of diet on colon 25 cancer risk. J Nutr 2009; 139: 2044-2048 [PMID: 19741203 DOI: 10.3945/jn.109.104380]
15. Rossi M, Amaretti A, Raimondi S. Folate production by pro- 26 biotic bacteria. Nutrients 2011; 3: 118-134 [PMID: 22254078 DOI: 10.3390/nu3010118]
16. MacPhee RA, Hummelen R, Bisanz JE, Miller WL, Reid G. Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother 2010; 11: 2985-2995 [PMID: 21080853 DOI: 10.1517/14656566.2010.51200]
17. Williams NT. Probiotics. Am J Health Syst Pharm 2010; 67: 449-458 [PMID: 20208051 DOI: 10.2146/ajhp090168]
18. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296-301 [PMID: 14695889 DOI: 10.1073/ 29 pnas.2434651100]
19. Yang H, Ochani M, Li J, Qiang X, anovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton J, Andersson U, Tracey KJ. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296-301.[PMID: 14695889 DOI: 10.1073/pnas.2434651100]
20. Johnson-Henry KC, Nadjafi M, Avitzur Y, Mitchell DJ, Ngan BY, Galindo-Mata E, Jones NL, Sherman PM. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 2005; 191: 2106-2117 [PMID: 15897997]
21. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55: 1553-1560 [PMID: 16638791 DOI: 10.1136/gut.2005.080739]
22. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517-524 [PMID: 12724763 DOI: 10.1038/nm0503-517]
23. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195 [PMID: 12110890 DOI: 10.1038/nature00858]
24. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012; 9: 577-589 [PMID: 22945443 DOI: 10.1038/nrgas- tro.2012.156]
25. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9: 599-608 [PMID: 22907164]
26. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez- Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-16736 [PMID: 18936492 DOI: 10.1073/ pnas.0804812105]
27. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15: 1183-1189 [PMID: 19235886 DOI: 10.1002/ibd.20903]
28. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Mo- mose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337-341 [PMID: 21205640 DOI: 10.1126/science.1198469]
29. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31: 677-689 [PMID: 19833089 DOI: 10.1016/j.immuni.2009.08.020]
30. Ivanov II, Atarashi K, Manel N, rodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-498 [PMID: 19836068 DOI: 10.1016/j.cell.2009.09.033]